Literature DB >> 21912765

Hepatosplenic lymphoma presenting initially as hemophagocytic syndrome in a 21-year-old man with Crohn's disease: a case report and literature review.

Justin Côté-Daigneault1, Edmond-Jean Bernard.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21912765      PMCID： PMC3186725          DOI： 10.1155/2011/148927

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN： 0835-7900            Impact factor:   3.522


× No keyword cloud information.
  10 in total

1.  HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

Authors:  Jan-Inge Henter; Annacarin Horne; Maurizio Aricó; R Maarten Egeler; Alexandra H Filipovich; Shinsaku Imashuku; Stephan Ladisch; Ken McClain; David Webb; Jacek Winiarski; Gritta Janka
Journal:  Pediatr Blood Cancer       Date:  2007-02       Impact factor: 3.167

2.  Infliximab, azathioprine, or combination therapy for Crohn's disease.

Authors:  Jean Frédéric Colombel; William J Sandborn; Walter Reinisch; Gerassimos J Mantzaris; Asher Kornbluth; Daniel Rachmilewitz; Simon Lichtiger; Geert D'Haens; Robert H Diamond; Delma L Broussard; Kezhen L Tang; C Janneke van der Woude; Paul Rutgeerts
Journal:  N Engl J Med       Date:  2010-04-15       Impact factor: 91.245

3.  Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy.

Authors:  Harry Sokol; Philippe Seksik; Fabrice Carrat; Isabelle Nion-Larmurier; Ariane Vienne; Laurent Beaugerie; Jacques Cosnes
Journal:  Gut       Date:  2010-06-29       Impact factor: 23.059

Review 4.  Hepatosplenic T-cell lymphoma in a young man with Crohn's disease: case report and literature review.

Authors:  Mark G Ochenrider; David J Patterson; David M Aboulafia
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2010-04

5.  Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France.

Authors:  Xavier Mariette; Dominique Cazals-Hatem; Josiane Warszawki; Frédéric Liote; Nathalie Balandraud; Jean Sibilia
Journal:  Blood       Date:  2002-06-01       Impact factor: 22.113

6.  Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment.

Authors:  G S Falchook; F Vega; N H Dang; F Samaniego; M A Rodriguez; R E Champlin; C Hosing; S Verstovsek; B Pro
Journal:  Ann Oncol       Date:  2009-02-23       Impact factor: 32.976

7.  Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

Authors:  Laurent Beaugerie; Nicole Brousse; Anne Marie Bouvier; Jean Frédéric Colombel; Marc Lémann; Jacques Cosnes; Xavier Hébuterne; Antoine Cortot; Yoram Bouhnik; Jean Pierre Gendre; Tabassome Simon; Marc Maynadié; Olivier Hermine; Jean Faivre; Fabrice Carrat
Journal:  Lancet       Date:  2009-11-07       Impact factor: 79.321

8.  Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials.

Authors:  Laurent Peyrin-Biroulet; Pierre Deltenre; Nicolas de Suray; Julien Branche; William J Sandborn; Jean-Frédéric Colombel
Journal:  Clin Gastroenterol Hepatol       Date:  2008-06       Impact factor: 11.382

9.  Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis.

Authors:  Corey A Siegel; Sadie M Marden; Sarah M Persing; Robin J Larson; Bruce E Sands
Journal:  Clin Gastroenterol Hepatol       Date:  2009-01-24       Impact factor: 11.382

10.  Fatal Epstein-Barr virus primo infection in a 25-year-old man treated with azathioprine for Crohn's disease.

Authors:  Y N'guyen; L Andreoletti; M Patey; C Lecoq-Lafon; P Cornillet; A Léon; R Jaussaud; C Fieschi; C Strady
Journal:  J Clin Microbiol       Date:  2009-02-04       Impact factor: 5.948
  10 in total
  6 in total

Review 1.  Update on the Use of Thiopurines and Methotrexate in Inflammatory Bowel Disease.

Authors:  Christopher M Johnson; Themistocles Dassopoulos
Journal:  Curr Gastroenterol Rep       Date:  2018-09-28

2.  Systematic review: hepatosplenic T-cell lymphoma on biologic therapy for inflammatory bowel disease, including data from the Food and Drug Administration Adverse Event Reporting System.

Authors:  Eric D Shah; Elliot S Coburn; Anil Nayyar; Kerry Jo Lee; Jenna L Koliani-Pace; Corey A Siegel
Journal:  Aliment Pharmacol Ther       Date:  2020-01-28       Impact factor: 8.171

3.  Hepatosplenic T-cell lymphoma arising in patients with immunodysregulatory disorders: a study of 7 patients who did not receive tumor necrosis factor-α inhibitor therapy and literature review.

Authors:  Mariko Yabe; L Jeffrey Medeiros; Yahya Daneshbod; Masoud Davanlou; Carlos E Bueso-Ramos; Elisa J Moran; Ken H Young; Roberto N Miranda
Journal:  Ann Diagn Pathol       Date:  2016-10-18       Impact factor: 2.090

4.  Hemophagocytic lymphohistiocytosis caused by primary Epstein-Barr virus in patient with Crohn's disease.

Authors:  Francesco Virdis; Sara Tacci; Federico Messina; Massimo Varcada
Journal:  World J Gastrointest Surg       Date:  2013-11-27

Review 5.  Hemophagocytic Lymphohistiocytosis and Inflammatory Bowel Disease: Case Report and Systematic Review.

Authors:  Bárbara Brambilla; Amanda Machado Barbosa; Cassiano da Silva Scholze; Floriano Riva; Lislene Freitas; Raul Angelo Balbinot; Silvana Balbinot; Jonathan Soldera
Journal:  Inflamm Intest Dis       Date:  2020-03-10

6.  Hemophagocytic lymphohistiocytosis associated with hepatosplenic T-cell lymphoma: case report.

Authors:  Vitor Ribeiro Paes; Patrícia Picciarelli de Lima; Sheila Aparecida Coelho Siqueira
Journal:  Autops Case Rep       Date:  2014-03-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.